Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hsueh-Chou Lai (H-C Lai)

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 3

Top Topics

Patient Reported Outcomes

Metastatic Renal Cell Carcinoma

Top Venues

Journal of gastroenterology and hepatology

Infection & chemotherapy

Alimentary pharmacology & therapeutics

China Medical University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

China Medical University Jul 20o 1993

Taiwan

Attending Physician :: Division of Hepato-Gastroenterology, Department of Internal Medicine

Publications

Chen-Sheng Lin, Su-Hua Huang, Bo-Yu Yan, Hsueh-Chou Lai, Cheng-Wen Lin
Effective Antiviral Activity of the Tyrosine Kinase Inhibitor Sunitinib Malate against Zika Virus. Infection & chemotherapy 53 (4) (2021)
K-F Liao, Hsueh-Chou Lai, C-L Lin, Shih-Wei Lai
Letter: cohort study examining the association between proton pump inhibitor therapy and risk of hepatocellular carcinoma in Taiwan. Alimentary pharmacology & therapeutics 48 (6) (2019)
Hung-Wei Wang, Hsueh-Chou Lai, Tsung-Hui Hu, Wen-Pang Su, Sheng-Nan Lu, Chia-Hsin Lin, Chao-Hung Hung, Po-Heng Chuang, Jing-Houng Wang, Mei-Hsuan Lee, Chien-Hung Chen, Cheng-Yuan Peng
Stratification of hepatocellular carcinoma risk through modified FIB-4 index in chronic hepatitis B patients on entecavir therapy. Journal of gastroenterology and hepatology 34 (2) (2018)